At the time of writing, Bristol-Myers Squibb Co [BMY] stock is trading at $54.71, up 0.79%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BMY shares have gain 2.17% over the last week, with a monthly amount glided 14.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bristol-Myers Squibb Co [NYSE: BMY] stock has seen the most recent analyst activity on December 15, 2025, when BofA Securities upgraded its rating to a Buy but kept the price target unchanged to $61 for it. Previously, Guggenheim upgraded its rating to Buy on December 12, 2025, and kept the price target unchanged to $62. On November 13, 2025, Scotiabank initiated with a Sector Perform rating and assigned a price target of $45 on the stock. Daiwa Securities downgraded its rating to a Neutral but stick to its price target of $42 on August 05, 2025. Piper Sandler initiated its recommendation with an Overweight. Cantor Fitzgerald started tracking with a Neutral rating for this stock on April 22, 2025, and assigned it a price target of $55. In a note dated December 16, 2024, Jefferies upgraded a Buy rating on this stock but restated the target price of $70.
For the past year, the stock price of Bristol-Myers Squibb Co fluctuated between $42.52 and $63.33. Currently, Wall Street analysts expect the stock to reach $52 within the next 12 months. Bristol-Myers Squibb Co [NYSE: BMY] shares were valued at $54.71 at the most recent close of the market. An investor can expect a potential drop of -4.95% based on the average BMY price forecast.
Analyzing the BMY fundamentals
According to Bristol-Myers Squibb Co [NYSE:BMY], the company’s sales were 48.03B for trailing twelve months, which represents an -0.97% plunge. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.35 and Total Capital is 0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 54.35 points at the first support level, and at 54.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 54.90, and for the 2nd resistance point, it is at 55.10.
Ratios To Look Out For
It is important to note that Bristol-Myers Squibb Co [NYSE:BMY] has a current ratio of 1.27. In addition, the Quick Ratio stands at 1.17 and the Cash Ratio stands at 0.56. Considering the valuation of this stock, the price to sales ratio is 2.32, the price to book ratio is 6.00 and price to earnings (TTM) ratio is 18.47.
Transactions by insiders
Recent insider trading involved Elkins David V, EVP, Chief Financial Officer, that happened on Sep 02 ’25 when 56000.0 shares were sold. Officer, Elkins David V completed a deal on Sep 02 ’25 to buy 56000.0 shares. Meanwhile, EVP, Corporate Affairs Short Bartie Wendy sold 378.0 shares on Aug 02 ’25.
